InvestorsHub Logo
Followers 16
Posts 1523
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Friday, 08/06/2021 10:00:08 AM

Friday, August 06, 2021 10:00:08 AM

Post# of 17441
Yesterday's earnings commentary vaguely alluded to Covid related issues hampering the launch. Going from nearly -0- sales in the first quarter (when there was less than two months to produce sales) to over 6 million in the second quarter tells me initial acceptance has been solid, more infrastructure has been created, and growth could become exponential from here. One of the subscription hawking companies mentioned Pfizer yesterday as an example of a good fit for Aurinia.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News